Roche announces Japanese court ruled in favour of Chugai in Hemlibra patent litigation

Roche today announced that a Japanese court (Tokyo District Court) ruled in favour of Chugai Pharmaceutical Co., Ltd, a member of the Roche Group, in the patent litigation case relating to Hemlibra ® (emicizumab).
Source: Roche Media News - Category: Pharmaceuticals Source Type: news